Reproduction   citetrack
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Reproduction (2006) 132 207-215
DOI: 10.1530/rep.1.01073
Copyright © 2006 Society for Reproduction and Fertility
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilezikjian, L. M
Right arrow Articles by Vale, W. W
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilezikjian, L. M
Right arrow Articles by Vale, W. W

REVIEW

Pituitary actions of ligands of the TGF-ß family: activins and inhibins

Louise M Bilezikjian, Amy L Blount, Cindy J Donaldson and Wylie W Vale

The Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, California 92037, USA

Correspondence should be addressed to L M Bilezikjian; Email: bilezikjian{at}salk.edu

Activins, as members of the transforming growth factor-ß superfamily, control and orchestrate many physiological processes and are vital for the development, growth and functional integrity of most tissues, including the pituitary. Activins produced by pituitary cells work in conjunction with central, peripheral, and other local factors to influence the function of gonadotropes and maintain a normal reproductive axis. Follistatin, also produced by the pituitary, acts as a local buffer to bind activin and modulate its bioactivity. On the other hand, inhibins of gonadal origin provide an endocrine feedback signal to antagonize activin signaling in cells that express the inhibin co-receptor, betaglycan, such as gonadotropes. This review highlights the pituitary roles of activin and the mechanisms through which these actions are modulated by inhibin and follistatin.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
A. L. Blount, J. M. Vaughan, W. W. Vale, and L. M. Bilezikjian
A Smad-binding Element in Intron 1 Participates in Activin-dependent Regulation of the Follistatin Gene
J. Biol. Chem., March 14, 2008; 283(11): 7016 - 7026.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
T. L. McCarthy, T. H. Pham, B. I. Knoll, and M. Centrella
Prostaglandin E2 Increases Transforming Growth Factor-{beta} Type III Receptor Expression through CCAAT Enhancer-Binding Protein {delta} in Osteoblasts
Mol. Endocrinol., November 1, 2007; 21(11): 2713 - 2724.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
Q. Li, J. M. Graff, A. E. O'Connor, K. L. Loveland, and M. M. Matzuk
SMAD3 Regulates Gonadal Tumorigenesis
Mol. Endocrinol., October 1, 2007; 21(10): 2472 - 2486.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
B. D. Looyenga and G. D. Hammer
Genetic Removal of Smad3 from Inhibin-Null Mice Attenuates Tumor Progression by Uncoupling Extracellular Mitogenic Signals from the Cell Cycle Machinery
Mol. Endocrinol., October 1, 2007; 21(10): 2440 - 2457.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
A. Drummond and J. Findlay
Focus on TGF-{beta} signalling.
Reproduction, August 1, 2006; 132(2): 177 - 178.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS  
Copyright © 2006 by the Society for Reproduction and Fertility.